Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JE. Chlebowski RT, et al. Among authors: aragaki ak. J Natl Cancer Inst. 2015 Dec 14;108(3):djv350. doi: 10.1093/jnci/djv350. Print 2016 Mar. J Natl Cancer Inst. 2015. PMID: 26668177 Free PMC article. Clinical Trial.
Effects of estrogen plus progestin on health-related quality of life.
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG; Women's Health Initiative Investigators. Hays J, et al. Among authors: aragaki ak. N Engl J Med. 2003 May 8;348(19):1839-54. doi: 10.1056/NEJMoa030311. Epub 2003 Mar 17. N Engl J Med. 2003. PMID: 12642637 Free article. Clinical Trial.
Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR; Women's Health Initiative Investigators. Barnabei VM, et al. Among authors: aragaki ak. Obstet Gynecol. 2005 May;105(5 Pt 1):1063-73. doi: 10.1097/01.AOG.0000158120.47542.18. Obstet Gynecol. 2005. PMID: 15863546 Clinical Trial.
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators. McTiernan A, et al. Among authors: aragaki ak. J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279. J Natl Cancer Inst. 2005. PMID: 16174858 Clinical Trial.
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J; WHI Investigators. Hendrix SL, et al. Circulation. 2006 May 23;113(20):2425-34. doi: 10.1161/CIRCULATIONAHA.105.594077. Epub 2006 May 15. Circulation. 2006. PMID: 16702472 Clinical Trial.
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators. Chlebowski RT, et al. Among authors: aragaki ak. J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. doi: 10.1093/jnci/djm224. Epub 2007 Nov 13. J Natl Cancer Inst. 2007. PMID: 18000216
151 results